Alert: Canvas Outage
CU is aware that Canvas is unavailable and the webpage temporarily displayed a message regarding a security breach of Canvas. The site is now displaying a maintenance message. CU is working with the vendor to investigate and resolve the issue. CU does not control the platform. We cannot provide a timeline for resolution. This incident is impacting Canvas instances globally and is part of the larger data breach reported to you on Monday. We will provide additional updates as they are available.
CU is aware that Canvas is unavailable and the webpage temporarily displayed a message regarding a security breach of Canvas. The site is now displaying a maintenance message. CU is working with the vendor to investigate and resolve the issue. CU does not control the platform. We cannot provide a timeline for resolution. This incident is impacting Canvas instances globally and is part of the larger data breach reported to you on Monday. We will provide additional updates as they are available.
Learn More
Daniel Welch
Gates Institute Advisory Board
Dan has spent his career of 40 years in the business of developing medicines in both biotech and multi-national pharmaceutical companies. He has had an executive leadership or board director role in bringing over a dozen breakthrough new medicines to patients with HIV, Multiple Sclerosis, cardiovascular disease, cancer, infectious disease and rare diseases.
Dan currently serves as the Chairman of the Board or board director of several public and private biotech companies that are developing medicines and gene therapies to treat various forms of cancer, rare diseases and cardiovascular disease.
Dan holds a B.A. degree from the University of Miami and an MBA from the University of North Carolina. He has published a novel, Race for the Mind, in which the main characters are biotech CEOs. He and his family live in Denver.